Azithromycin ineffective for secondary coronary heart disease

Affiliations

Comment

Andrea D Tribastone. J Fam Pract. 2004 Jan.

. 2004 Jan;53(1):16-7.

¹ Department of Family Medicine, University of Virginia, Stoney Creek Family Practice, Nellysford, VA, USA. adg5a@hscmail.mcc.virginia.edu

No abstract available

Comment on

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
O'Connor CM, Dunne MW, Pfeffer MA, Muhlestein JB, Yao L, Gupta S, Benner RJ, Fisher MR, Cook TD; Investigators in the WIZARD Study. O'Connor CM, et al. JAMA. 2003 Sep 17;290(11):1459-66. doi: 10.1001/jama.290.11.1459. JAMA. 2003. PMID: 13129985 Clinical Trial.